Tag: veterinary cro and cdmo market overview.

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Veterinary CRO And CDMO Market Between 2025 And 2029?

The size of the veterinary CRO and CDMO market has demonstrated substantial growth in recent years. It is projected to expand from $6.97 billion in 2024 to $7.53 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.0%. The market’s historical expansion is largely due to factors such as regulatory compliance requirements, the increasing globalization of the animal health market, intensified drug development efforts for livestock, and a rise in outsourcing activities by pharmaceutical companies.

The veterinary CRO and CDMO market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a value of $10.71 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.2%. The anticipated expansion during this forecast period stems from factors such as the rising implementation of precision medicine, a greater emphasis on preventive healthcare, comprehensive epidemiological surveillance, enhanced emergency preparedness, and the growing intricacy of veterinary therapeutics. Key trends expected during the forecast timeframe encompass the outsourcing of research and development activities, technological integration, strategic collaborations and partnerships, an emphasis on sustainability within manufacturing processes, and the digitalization of veterinary services.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

What Are The Key Drivers Of Growth In The Veterinary CRO And CDMO Market?

The expansion of the veterinary CRO and CDMO market is anticipated to be fueled by rising investments in animal healthcare. This increase in animal healthcare investments over recent years stems from heightened awareness regarding animal well-being and a growing need for veterinary services and products, thereby contributing to the development of the veterinary CRO and CDMO market. For example, data from October 2023, shared by the American Pet Products Association (APPA), a US-based non-profit dedicated to pet ownership and the pet products sector, revealed that pet care spending within the U.S. rose from USD 123.6 billion in 2021 to USD 136.8 billion in 2022. Consequently, the surge in animal healthcare investments is poised to stimulate the growth of the veterinary CRO and CDMO market.

How Is The Veterinary CRO And CDMO Market Classified Into Different Segments?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance

Which Key Trends Are Expected To Influence The Veterinary CRO And CDMO Market In The Coming Years?

Product innovation is a key trend growing in popularity within the veterinary CRO and CDMO market. Businesses operating in the veterinary CRO and CDMO markets are focusing on new product developments to sustain their market standing. For instance, in June 2022, Vetio, a US-based Contract Development and Manufacturing Organization (CDMO) dedicated to animal health, was granted an Intention to Grant by the European Patent Office (EPO) and a Notice of Allowance by the United States Patent Office (USPTO) for its Starch-Free Soft Chew designed for veterinary applications. Vetio’s Soft Chew Technology platform, specifically developed for animal health, is excellently tailored to deliver one or more active ingredients in a high-quality dosage form suitable for veterinary pharmaceutical use. Vetio’s innovative composition and manufacturing process is free from starch and added water, making it highly suitable for moisture-sensitive active ingredients.

Which Leading Players Are Enhancing Their Veterinary CRO And CDMO Market Presence Worldwide?

Major companies operating in the veterinary cro and cdmo market include Eurofins Scientific SE, Pharmaceutical Product Development Inc., Syneos Health Inc., Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited., Inotiv Inc., Promega Corporation, Aenova Group, Sai Life Sciences Ltd., Taconic Bioscience Inc., Avid Bioservices Inc., Frontage Laboratories Inc., Angion Biomedica Corp., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Triveritas Ltd., Cebiphar, Ondax Scientific UK Ltd., Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

How Does The Veterinary CRO And CDMO Market Perform Across Key Geographic Regions?

North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Veterinary CRO And CDMO Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12080&type=smp

Browse Through More Reports Similar to the Global Veterinary CRO And CDMO Market 2025, By The Business Research Company

Veterinary Infectious Disease Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Veterinary CRO And CDMO Market Expected to Grow Between 2025 And 2029?

In recent times, the size of the veterinary CRO and CDMO market has seen significant growth. The market size is projected to expand from $6.97 billion in 2024 to $7.53 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.0%. The historical growth can be associated with factors such as the need for regulatory compliance, the globalization of the animal health market, augmented drug development for livestock, and an increase in outsourcing by pharmaceutical companies.

In the coming years, the market size for the veterinary contract research organization and contract development and manufacturing organization is predicted to see notable expansion. It’s anticipated to reach $10.71 billion by 2029, with a compound annual growth rate (CAGR) of 9.2%. The growth during this forecast period can be linked to factors such as the rising embracement of precision medicine, emphasis on preventive healthcare, epidemiological surveillance, emergency readiness, and the growing intricacy of veterinary therapeutics. Key trends forecasted for this period encompass the outsourcing of R&D, tech integration, strategic collaborations and partnerships, sustainable manufacturing practices, and the digital transition in veterinary services.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

What External and Internal Drivers Are Contributing to the Growth of theVeterinary CRO And CDMO Market?

The veterinary CRO and CDMO market is anticipated to be driven by the growth in investments in animal healthcare. The escalating awareness regarding animal health and the surging demand for veterinary services and products have stimulated more investments in animal healthcare in recent years, thereby enhancing the growth parameters of the veterinary CRO and CDMO market. For example, the American Pet Products Association (APPA), a not-for-profit organization based in the US which encourages and advances pet ownership and the pet product industry, published a report in October 2023 stating that the expenditure on pet care in the U.S. surged from USD 123.6 billion in 2021 to USD 136.8 billion in 2022. Consequently, the growth of the veterinary CRO and CDMO market will be fueled by these advancements in the investment landscape of animal healthcare.

What Segment Types Define the Veterinary CRO And CDMO Market Structure?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12080&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Veterinary CRO And CDMO Market?

North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Veterinary CRO And CDMO Market?

The advancement of product innovations is a primary trend getting traction in the veterinary CRO and CDMO market. Entities operating in these markets are focused on introducing innovative products as a strategy to stay relevant. For instance, Vetio, a US-based Contract Development and Manufacturing Organization (CDMO) that specializes in animal health, received an Intention to Grant from the European Patent Office (EPO) and a Notice of Allowance from the United States Patent Office (USPTO) in June 2022 for its Starch-Free Soft Chew created for veterinary applications. Vetio’s Soft Chew Technology platform, which has been crafted especially for animal health, is meticulously developed to administer one or more active ingredients in a high-quality dosage format suitable for veterinary pharmaceutical usage. With a composition and production process that eliminates the use of starch and added water, Vetio’s innovative offering is ideal for moisture-sensitive active ingredients.

View the full report here:

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

What Is the Definition of the Veterinary CRO And CDMO Market?

A veterinary CRO is a specialized service provider that conducts research and clinical trials to evaluate the safety and efficacy of veterinary drugs and healthcare products, and a veterinary CDMO is a specialized service provider that offers contract development and manufacturing services for veterinary drugs and healthcare products, assisting with formulation development, process optimization, and production.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12080

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Veterinary CRO And CDMO Market Growth in 2025?

In recent times, there has been significant growth in the market size of the veterinary contract research organization (cro) and contract development manufacturing organization (cdmo). Its size is projected to escalate from $6.97 billion in 2024 to $7.55 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. The growth experienced in the retrospective period can be credited to regulatory compliance requirements, expansion of the global animal health market, amplified drug development for livestock, and increased outsourcing by pharmaceutical companies.

What Is the Forecast for the Veterinary CRO And CDMO Market Size Through 2029?

The market size of veterinary cro and cdmo is anticipated to witness substantial growth over the coming years, expanding to $10.74 billion in 2029 with a compound annual growth rate (CAGR) of 9.2%. This projected growth within the forecast period can be ascribed to factors such as enhanced adoption of precision medicine, commitment to preventive healthcare, increasing complication in veterinary therapeutics, epidemiological surveillance, and emergency preparedness. Key trends expected during this period encompass the outsourcing of R&D, technological integration, alliances and partnerships, sustainability in production, and the digitisation of veterinary services.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

What are the Key Market Players in Veterinary CRO And CDMO Market and How They’re Evolving?

Major companies operating in the veterinary cro and cdmo market include Eurofins Scientific SE, Pharmaceutical Product Development Inc., Syneos Health Inc., Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited., Inotiv Inc., Promega Corporation, Aenova Group, Sai Life Sciences Ltd., Taconic Bioscience Inc., Avid Bioservices Inc., Frontage Laboratories Inc., Angion Biomedica Corp., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Triveritas Ltd., Cebiphar, Ondax Scientific UK Ltd., Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l.

What Are the Primary Growth Drivers in the Veterinary CRO And CDMO Market?

The surge in funding for animal healthcare is predicted to fuel the expansion of the veterinary CRO and CDMO market. There has been a rising trend in animal healthcare investments in recent years, largely due to heightened understanding of animal health significance and the burgeoning demand for veterinary services and goods, which have collectively influenced the veterinary CRO and CDMO market expansion. For example, a report by the American Pet Products Association (APPA), a non-profit organization based in the US that advocates and promotes pet ownership and the pet product industry, shows that the pet care expenditure in the U.S. saw a rise from USD 123.6 billion in 2021 to 136.8 billion in 2022, as of October 2023. Hence, the escalating investments in animal healthcare are anticipated to facilitate the growth of the veterinary CRO and CDMO market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12080&type=smp

What Are the Leading Segments in the Global Veterinary CRO And CDMO Industry?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance

What Are the Key Market Trends in the Veterinary CRO And CDMO Industry?

One popular trend sweeping the veterinary CRO and CDMO market is that of product innovation. To maintain their competitive edge, companies in the veterinary CRO and CDMO space are concentrating on developing unique products. For example, in June 2022, Vetio, a US-based Contract Development and Manufacturing Organization exclusively catering to the field of animal health, received an Intention to Grant from the European Patent Office (EPO) and a Notice of Allowance from the United States Patent Office (USPTO) for its Starch-Free Soft Chew designed for veterinary use. Vetio’s Soft Chew Technology platform, specifically engineered for pet health, is wonderfully designed to administer one or more active compounds in a superior quality dosage form ideal for veterinary medicine. Vetio’s cutting-edge formulation and production process does not include starch or extra water, rendering it very suitable for active ingredients sensitive to moisture.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

What Is the Regional Outlook for the Veterinary CRO And CDMO Market?

North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12080

This Report Delivers Insight On:

1. How big is the veterinary cro and cdmo market, and how is it changing globally?

2. Who are the major companies in the veterinary cro and cdmo market, and how are they performing?

3. What are the key opportunities and risks in the veterinary cro and cdmo market right now?

4. Which products or customer segments are growing the most in the veterinary cro and cdmo market?

5. What factors are helping or slowing down the growth of the veterinary cro and cdmo market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the veterinary cro and cdmo industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the Veterinary CRO And CDMO Market Size From 2025 to 2034?

In recent times, there has been significant growth in the market size of the veterinary contract research organization (cro) and contract development manufacturing organization (cdmo). Its size is projected to escalate from $6.97 billion in 2024 to $7.55 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. The growth experienced in the retrospective period can be credited to regulatory compliance requirements, expansion of the global animal health market, amplified drug development for livestock, and increased outsourcing by pharmaceutical companies.

The market size of veterinary cro and cdmo is anticipated to witness substantial growth over the coming years, expanding to $10.74 billion in 2029 with a compound annual growth rate (CAGR) of 9.2%. This projected growth within the forecast period can be ascribed to factors such as enhanced adoption of precision medicine, commitment to preventive healthcare, increasing complication in veterinary therapeutics, epidemiological surveillance, and emergency preparedness. Key trends expected during this period encompass the outsourcing of R&D, technological integration, alliances and partnerships, sustainability in production, and the digitisation of veterinary services.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theVeterinary CRO And CDMO Market?

The surge in funding for animal healthcare is predicted to fuel the expansion of the veterinary CRO and CDMO market. There has been a rising trend in animal healthcare investments in recent years, largely due to heightened understanding of animal health significance and the burgeoning demand for veterinary services and goods, which have collectively influenced the veterinary CRO and CDMO market expansion. For example, a report by the American Pet Products Association (APPA), a non-profit organization based in the US that advocates and promotes pet ownership and the pet product industry, shows that the pet care expenditure in the U.S. saw a rise from USD 123.6 billion in 2021 to 136.8 billion in 2022, as of October 2023. Hence, the escalating investments in animal healthcare are anticipated to facilitate the growth of the veterinary CRO and CDMO market.

Which Segments in the Veterinary CRO And CDMO Offer the Most Growth?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=12080&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theVeterinary CRO And CDMO Market?# Market?

North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Veterinary CRO And CDMO Industry?

One popular trend sweeping the veterinary CRO and CDMO market is that of product innovation. To maintain their competitive edge, companies in the veterinary CRO and CDMO space are concentrating on developing unique products. For example, in June 2022, Vetio, a US-based Contract Development and Manufacturing Organization exclusively catering to the field of animal health, received an Intention to Grant from the European Patent Office (EPO) and a Notice of Allowance from the United States Patent Office (USPTO) for its Starch-Free Soft Chew designed for veterinary use. Vetio’s Soft Chew Technology platform, specifically engineered for pet health, is wonderfully designed to administer one or more active compounds in a superior quality dosage form ideal for veterinary medicine. Vetio’s cutting-edge formulation and production process does not include starch or extra water, rendering it very suitable for active ingredients sensitive to moisture.

View the full report here:

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

What Are the Key Elements That Define the Veterinary CRO And CDMO Market?

A veterinary CRO is a specialized service provider that conducts research and clinical trials to evaluate the safety and efficacy of veterinary drugs and healthcare products, and a veterinary CDMO is a specialized service provider that offers contract development and manufacturing services for veterinary drugs and healthcare products, assisting with formulation development, process optimization, and production.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12080

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theVeterinary CRO And CDMO Market?

The upward trend in investments towards animal healthcare is anticipated to fuel the expansion of the veterinary CRO and CDMO market. The awareness about the significance of animal health has been on the rise, along with an escalated demand for veterinary products and services, thereby boosting the growth of this market. For instance, information from the American Pet Products Association (APPA), an American non-profit aimed at promoting pet ownership and the pet product industry, showed that the expenses on pet care in the U.S. escalated from USD 123.6 billion in 2021 to a robust 136.8 billion in 2022, which was published in October 2023. Consequently, this surge in animal healthcare investments is predicted to act as a catalyst for the growth of the veterinary CRO and CDMO market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

#What Are the Key Projections for the CAGR of the Veterinary CRO And CDMO Market From 2025 to 2034?

The market size of veterinary cro and cdmo has seen robust growth in recent times. The growth projection asserts that the market will expand from $6.97 billion in 2024 to $7.55 billion in 2025, boasting a Compound Annual Growth Rate (CAGR) of 8.3%. The historical growth is in part linked to the need for regulatory compliance, the internationalization of the animal health market, enhanced drug development for farm animals, and a boost in outsourcing by pharmaceutical firms.

The market size of the veterinary cro and cdmo sector is projected to witness a considerable increase in the ensuing years. By 2029, it’s anticipated to be valued at $10.74 billion, expanding at a Compound Annual Growth Rate (CAGR) of 9.2%. The growth during this forecast period is attributable to the rising adoption of precision medicine, emphasis on preventive healthcare, epidemiological surveillance, preparedness for emergencies and the escalating complexity of veterinary therapeutics. Significant trends predicted to be observed in this period encompass the outsourcing of research & development, blending of technology, formation of collaborations and partnerships, sustainability in the production process and the digitization of veterinary services.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12080

What Are the Current Market Growth and Trends in theVeterinary CRO And CDMO Market That Industry Players Should Watch?

The primary trend gaining traction in the veterinary CRO and CDMO market is product innovation. Corporations in these markets are emphasizing novel product development to maintain their industry standing. For example, in June 2022, Vetio, a US-based Contract Development and Manufacturing Organization (CDMO) committed to animal health, received an Intention to Grant from the European Patent Office (EPO) and a Notice of Allowance from the United States Patent Office (USPTO) for its Starch-Free Soft Chew, formulated specifically for veterinary use. Vetio’s Soft Chew Technology platform, which was created explicitly for animal health, is adeptly designed to administer one or more active ingredients in a high-quality dosage form appropriate for veterinary pharmaceutical purposes. Vetio’s pioneering composition and manufacturing method, which involves no starch or added water, is particularly appropriate for moisture-sensitive active constituents.

What Are the Major Market Players Making an Impact on theVeterinary CRO And CDMO Market Growth?

Major companies operating in the veterinary cro and cdmo market include Eurofins Scientific SE, Pharmaceutical Product Development Inc., Syneos Health Inc., Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited., Inotiv Inc., Promega Corporation, Aenova Group, Sai Life Sciences Ltd., Taconic Bioscience Inc., Avid Bioservices Inc., Frontage Laboratories Inc., Angion Biomedica Corp., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Triveritas Ltd., Cebiphar, Ondax Scientific UK Ltd., Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

How Are the Key Segments of the Veterinary CRO And CDMO Market Driving Opportunities and Innovations?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=12080&type=smp

What Regions Are At the Forefront of #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theVeterinary CRO And CDMO Market?# Market Expansion?

North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Veterinary CRO And CDMO Maret 2025, By The Business Research Company:

Veterinary Infectious Disease Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Veterinary Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-healthcare-global-market-report

Veterinary Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the veterinary cro and cdmo market size evolved in recent years?

The market size of veterinary CRO and CDMO has significantly increased over recent years. It is predicted to expand from $6.97 billion in 2024 to $7.55 billion in 2025, with an impressive Compound Annual Growth Rate (CAGR) of 8.3%. The historical growth can be primarily attributed to factors such as the need for regulatory compliance, the globalization of the animal health market, an increase in drug development for livestock and greater outsourcing by pharmaceutical companies.

What are the predictions for the veterinary cro and cdmo market size in the coming years?

In the coming years, the market size for veterinary cro and cdmo is anticipated to witness robust growth. The market is projected to expand to a value of $10.74 billion by 2029, with a compound annual growth rate (CAGR) of 9.2%. The growth during this forecast period can be credited to the rising demand for precision medicine, emphasis on preventive health care, epidemiological surveillance, emergency readiness, and the growing intricacy of veterinary therapeutics. The forecast period is expected to be defined by increased outsourcing of research and development, advancements in technology integration, strategic collaborations and partnerships, sustainable manufacturing practices, and increased digitalization in veterinary services.

Get your veterinary cro and cdmo market report here!

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

What key factors are fueling the growth of the veterinary cro and cdmo market?

The anticipated boost in the veterinary CRO and CDMO market is driven by a rise in animal healthcare investments. The importance of animal health and an impactful demand for veterinary products and services have heightened awareness, leading to increased investments in animal healthcare. This, in turn, has a positive effect on the growth of the veterinary CRO and CDMO market. To illustrate, a report published by the American Pet Products Association (APPA), a non-profit U.S. organization endorsing pet ownership and the pet product industry, indicated that spending on pet care in the U.S. surged from USD 123.6 billion in 2021 to USD 136.8 billion in 2022. Consequently, the veterinary CRO and CDMO market is expected to benefit from this rise in investments for animal healthcare.

How is the global veterinary cro and cdmo market divided into key segments?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

Who are the key firms paving the way for growth in the veterinary cro and cdmo market?

Major companies operating in the veterinary cro and cdmo market include Eurofins Scientific SE, Pharmaceutical Product Development Inc., Syneos Health Inc., Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited., Inotiv Inc., Promega Corporation, Aenova Group, Sai Life Sciences Ltd., Taconic Bioscience Inc., Avid Bioservices Inc., Frontage Laboratories Inc., Angion Biomedica Corp., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Triveritas Ltd., Cebiphar, Ondax Scientific UK Ltd., Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l.

Which trends are expected to transform the veterinary cro and cdmo market?

Trend 1:

Driving the veterinary CRO and CDMO industry is a clear trend toward product advancement, with businesses putting a spotlight on novel creations to maintain their market stance. For instance, in June 2022, Vetio, an American veterinary-dedicated Contract Development and Manufacturing Organization (CDMO), received a signal of imminent patent award from both the European Patent Office (EPO) and the United States Patent Office (USPTO) for their Starch-Free Soft Chew developed for veterinary use. The technology behind Vetio’s Soft Chew, specifically formulated for animal health, offers an optimal method for delivering one or more active ingredients in a premium form suitable for veterinary pharmaceutical application. This pioneering composition and production procedure from Vetio eliminates starch and added water, thereby enhancing its compatibility with moisture-sensitive active ingredients.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12080

What regions are contributing significantly to the growth of the veterinary cro and cdmo market?

North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Veterinary Infectious Disease Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Veterinary Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-healthcare-global-market-report

Veterinary Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Veterinary CRO And CDMO Market Over the Coming Decade?

The veterinary CRO and CDMO market has grown significantly in recent years. It is expected to increase from $6.97 billion in 2024 to $7.55 billion in 2025 at a CAGR of 8.3%. The market’s past expansion has been driven by regulatory compliance requirements, the globalization of the animal health sector, increased drug development for livestock, and growing outsourcing by pharmaceutical companies.

The veterinary CRO and CDMO market is projected to see strong growth, reaching $10.74 billion by 2029 at a CAGR of 9.2%. Key growth factors include the increasing adoption of precision medicine, a greater focus on preventive healthcare, epidemiological surveillance, emergency preparedness measures, and the rising complexity of veterinary therapeutics. Major trends expected in this sector include the outsourcing of research and development, technological integration, strategic collaborations and partnerships, sustainable manufacturing practices, and the digital transformation of veterinary services.

Which Primary Drivers Are Supporting the Continued Expansion of the Market?

Increased investments in animal healthcare are expected to drive the growth of the veterinary CRO and CDMO market. Over recent years, spending on animal healthcare has risen due to growing awareness about animal health and the rising demand for veterinary products and services. This has positively impacted the veterinary CRO and CDMO market. For example, in October 2023, the American Pet Products Association (APPA) reported that pet care spending in the U.S. rose from USD 123.6 billion in 2021 to USD 136.8 billion in 2022. As a result, higher investments in animal healthcare will support the growth of the veterinary CRO and CDMO market.

Explore Comprehensive Insights Into The Global Veterinary CRO And CDMO Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

What Are the Major Players Making an Impact in the Veterinary CRO And CDMO Market’s Growth?

Major companies operating in the veterinary cro and cdmo market include:

• Eurofins Scientific SE

• Pharmaceutical Product Development Inc.

• Syneos Health Inc.

• Charles River Laboratories Inc.

• IDEXX Laboratories Inc.

Which Upcoming Trends Are Set to Influence the Veterinary CRO And CDMO Market’s Path Forward?

The veterinary CRO and CDMO market is being shaped by product innovations as companies focus on developing new solutions to maintain their market position. For instance, in June 2022, Vetio, a US-based Contract Development and Manufacturing Organization (CDMO) specializing in animal health, was granted an Intention to Grant by the European Patent Office (EPO) and a Notice of Allowance by the United States Patent Office (USPTO) for its Starch-Free Soft Chew formulation. This Soft Chew Technology platform, specifically designed for veterinary applications, offers an optimal dosage form for delivering active ingredients. The starch-free and water-free composition makes it particularly suitable for moisture-sensitive active ingredients, setting it apart from traditional formulations.

Secure Your Global Veterinary CRO And CDMO Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

What Are the Core Categories and Segments in the Veterinary CRO And CDMO Market Driving Demand and Growth?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance

What Regions Are Steering Growth in the Veterinary CRO And CDMO Sector?

North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Veterinary CRO And CDMO Market Classified and Defined in Market Analysis?

A veterinary CRO is a specialized service provider that conducts research and clinical trials to evaluate the safety and efficacy of veterinary drugs and healthcare products, and a veterinary CDMO is a specialized service provider that offers contract development and manufacturing services for veterinary drugs and healthcare products, assisting with formulation development, process optimization, and production.

Browse Through More Similar Reports By The Business Research Company:

Veterinary Infectious Disease Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Veterinary Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-healthcare-global-market-report

Veterinary Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Veterinary CRO And CDMO Market Over the Coming Decade?

The veterinary CRO and CDMO market has grown significantly in recent years. It is expected to increase from $6.97 billion in 2024 to $7.55 billion in 2025 at a CAGR of 8.3%. The market’s past expansion has been driven by regulatory compliance requirements, the globalization of the animal health sector, increased drug development for livestock, and growing outsourcing by pharmaceutical companies.

The veterinary CRO and CDMO market is projected to see strong growth, reaching $10.74 billion by 2029 at a CAGR of 9.2%. Key growth factors include the increasing adoption of precision medicine, a greater focus on preventive healthcare, epidemiological surveillance, emergency preparedness measures, and the rising complexity of veterinary therapeutics. Major trends expected in this sector include the outsourcing of research and development, technological integration, strategic collaborations and partnerships, sustainable manufacturing practices, and the digital transformation of veterinary services.

Which Primary Drivers Are Supporting the Continued Expansion of the Market?

Increased investments in animal healthcare are expected to drive the growth of the veterinary CRO and CDMO market. Over recent years, spending on animal healthcare has risen due to growing awareness about animal health and the rising demand for veterinary products and services. This has positively impacted the veterinary CRO and CDMO market. For example, in October 2023, the American Pet Products Association (APPA) reported that pet care spending in the U.S. rose from USD 123.6 billion in 2021 to USD 136.8 billion in 2022. As a result, higher investments in animal healthcare will support the growth of the veterinary CRO and CDMO market.

Explore Comprehensive Insights Into The Global Veterinary CRO And CDMO Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

What Are the Major Players Making an Impact in the Veterinary CRO And CDMO Market’s Growth?

Major companies operating in the veterinary cro and cdmo market include:

• Eurofins Scientific SE_x000D_

• Pharmaceutical Product Development Inc._x000D_

• Syneos Health Inc._x000D_

• Charles River Laboratories Inc._x000D_

• IDEXX Laboratories Inc._x000D_

Which Upcoming Trends Are Set to Influence the Veterinary CRO And CDMO Market’s Path Forward?

The veterinary CRO and CDMO market is being shaped by product innovations as companies focus on developing new solutions to maintain their market position. For instance, in June 2022, Vetio, a US-based Contract Development and Manufacturing Organization (CDMO) specializing in animal health, was granted an Intention to Grant by the European Patent Office (EPO) and a Notice of Allowance by the United States Patent Office (USPTO) for its Starch-Free Soft Chew formulation. This Soft Chew Technology platform, specifically designed for veterinary applications, offers an optimal dosage form for delivering active ingredients. The starch-free and water-free composition makes it particularly suitable for moisture-sensitive active ingredients, setting it apart from traditional formulations.

Secure Your Global Veterinary CRO And CDMO Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

What Are the Core Categories and Segments in the Veterinary CRO And CDMO Market Driving Demand and Growth?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance

What Regions Are Steering Growth in the Veterinary CRO And CDMO Sector?

North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Veterinary CRO And CDMO Market Classified and Defined in Market Analysis?

A veterinary CRO is a specialized service provider that conducts research and clinical trials to evaluate the safety and efficacy of veterinary drugs and healthcare products, and a veterinary CDMO is a specialized service provider that offers contract development and manufacturing services for veterinary drugs and healthcare products, assisting with formulation development, process optimization, and production.

Browse Through More Similar Reports By The Business Research Company:

Veterinary Infectious Disease Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Veterinary Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-healthcare-global-market-report

Veterinary Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Predicted Annual Growth Rate of the Veterinary CRO And CDMO Market Over the Coming Decade?

The veterinary CRO and CDMO market has grown significantly in recent years. It is expected to increase from $6.97 billion in 2024 to $7.55 billion in 2025 at a CAGR of 8.3%. The market’s past expansion has been driven by regulatory compliance requirements, the globalization of the animal health sector, increased drug development for livestock, and growing outsourcing by pharmaceutical companies.

The veterinary CRO and CDMO market is projected to see strong growth, reaching $10.74 billion by 2029 at a CAGR of 9.2%. Key growth factors include the increasing adoption of precision medicine, a greater focus on preventive healthcare, epidemiological surveillance, emergency preparedness measures, and the rising complexity of veterinary therapeutics. Major trends expected in this sector include the outsourcing of research and development, technological integration, strategic collaborations and partnerships, sustainable manufacturing practices, and the digital transformation of veterinary services.

Which Primary Drivers Are Supporting the Continued Expansion of the Market?

Increased investments in animal healthcare are expected to drive the growth of the veterinary CRO and CDMO market. Over recent years, spending on animal healthcare has risen due to growing awareness about animal health and the rising demand for veterinary products and services. This has positively impacted the veterinary CRO and CDMO market. For example, in October 2023, the American Pet Products Association (APPA) reported that pet care spending in the U.S. rose from USD 123.6 billion in 2021 to USD 136.8 billion in 2022. As a result, higher investments in animal healthcare will support the growth of the veterinary CRO and CDMO market.

Explore Comprehensive Insights Into The Global Veterinary CRO And CDMO Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12080&type=smp

What Are the Major Players Making an Impact in the Veterinary CRO And CDMO Market’s Growth?

Major companies operating in the veterinary cro and cdmo market include:

• Eurofins Scientific SE_x000D_

• Pharmaceutical Product Development Inc._x000D_

• Syneos Health Inc._x000D_

• Charles River Laboratories Inc._x000D_

• IDEXX Laboratories Inc._x000D_

Which Upcoming Trends Are Set to Influence the Veterinary CRO And CDMO Market’s Path Forward?

The veterinary CRO and CDMO market is being shaped by product innovations as companies focus on developing new solutions to maintain their market position. For instance, in June 2022, Vetio, a US-based Contract Development and Manufacturing Organization (CDMO) specializing in animal health, was granted an Intention to Grant by the European Patent Office (EPO) and a Notice of Allowance by the United States Patent Office (USPTO) for its Starch-Free Soft Chew formulation. This Soft Chew Technology platform, specifically designed for veterinary applications, offers an optimal dosage form for delivering active ingredients. The starch-free and water-free composition makes it particularly suitable for moisture-sensitive active ingredients, setting it apart from traditional formulations.

Secure Your Global Veterinary CRO And CDMO Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

What Are the Core Categories and Segments in the Veterinary CRO And CDMO Market Driving Demand and Growth?

The veterinary cro and cdmo market covered in this report is segmented –

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, market Approval And Post- marketing

2) By Animal Type: Companion Animals, Livestock Animals

3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications

Subsegments:

1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization

2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting

3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services

4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance

5) By market Approval And Post- marketing: Regulatory Submissions, Pharmacovigilance, Post- marketing Surveillance

What Regions Are Steering Growth in the Veterinary CRO And CDMO Sector?

North America was the largest region in the veterinary CRO and CDMO market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary CRO and CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Veterinary CRO And CDMO Market Classified and Defined in Market Analysis?

A veterinary CRO is a specialized service provider that conducts research and clinical trials to evaluate the safety and efficacy of veterinary drugs and healthcare products, and a veterinary CDMO is a specialized service provider that offers contract development and manufacturing services for veterinary drugs and healthcare products, assisting with formulation development, process optimization, and production.

Browse Through More Similar Reports By The Business Research Company:

Veterinary Infectious Disease Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-infectious-disease-diagnostics-global-market-report

Veterinary Healthcare Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-healthcare-global-market-report

Veterinary Pharmaceuticals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/veterinary-pharmaceuticals-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: